Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology

This article has been updated

Abstract

The human immunodeficiency virus-1 (HIV-1) envelope protein gp120 is the major contributor to the pathogenesis of HIV-associated neurocognitive disorder (HAND). Neuroinflammation plays a pivotal role in gp120-induced neuropathology, but how gp120 triggers neuroinflammatory processes and subsequent neuronal death remains unknown. Here, we provide evidence that NLRP3 is required for gp120-induced neuroinflammation and neuropathy. Our results showed that gp120-induced NLRP3-dependent pyroptosis and IL-1β production in microglia. Inhibition of microglial NLRP3 inflammasome activation alleviated gp120-mediated neuroinflammatory factor release and neuronal injury. Importantly, we showed that chronic administration of MCC950, a novel selective NLRP3 inhibitor, to gp120 transgenic mice not only attenuated neuroinflammation and neuronal death but also promoted neuronal regeneration and restored the impaired neurocognitive function. In conclusion, our data revealed that the NLRP3 inflammasome is important for gp120-induced neuroinflammation and neuropathology and suggest that NLRP3 is a potential novel target for the treatment of HAND.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Change history

  • 29 January 2026

    The original online version of this article was revised: Fig 8d and Supplementary Figure 5d have been updated.

References

  1. Saylor, D. et al. HIV-associated neurocognitive disorder—pathogenesis and prospects for treatment. Nat. Rev. Neurol. 12, 234–248 (2016).

    Google Scholar 

  2. Clifford, D. B. & Ances, B. M. HIV-associated neurocognitive disorder. Lancet Infect. Dis. 13, 976–986 (2013).

    Google Scholar 

  3. Eggers, C. et al. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J. Neurol. 264, 1715–1727 (2017).

    Google Scholar 

  4. Brenneman, D. E. et al. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335, 639–642 (1988).

    Google Scholar 

  5. Toggas, S. M. et al. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367, 188–193 (1994).

    Google Scholar 

  6. Kaul, M., Garden, G. A. & Lipton, S. A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410, 988–994 (2001).

    Google Scholar 

  7. Capo-Velez, C. M., Morales-Vargas, B., Garcia-Gonzalez, A. & Grajales-Reyes, J. G. The alpha7-nicotinic receptor contributes to gp120-induced neurotoxicity: implications in HIV-associated neurocognitive disorders. Sci. Rep. 8, 1829 (2018).

    Google Scholar 

  8. D’Hooge, R., Franck, F., Mucke, L. & De Deyn, P. P. Age-related behavioural deficits in transgenic mice expressing the HIV-1 coat protein gp120. Eur. J. Neurosci. 11, 4398–gp4402 (1999).

    Google Scholar 

  9. Gonzalez-Scarano, F. & Martin-Garcia, J. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5, 69–81 (2005).

    Google Scholar 

  10. Chen, N. C., Partridge, A. T., Sell, C., Torres, C. & Martin-Garcia, J. Fate of microglia during HIV-1 infection: from activation to senescence? Glia 65, 431–446 (2017).

    Google Scholar 

  11. Heneka, M. T., McManus, R. M. & Latz, E. Inflammasome signalling in brain function and neurodegenerative disease. Nat. Rev. Neurosci. 19, 610–621 (2018).

    Google Scholar 

  12. Mangan, M. S. J. et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat. Rev. Drug Disco. 17, 588–606 (2018).

    Google Scholar 

  13. Liu, X. et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153–158 (2016).

    Google Scholar 

  14. Song, L., Pei, L., Yao, S., Wu, Y. & Shang, Y. NLRP3 inflammasome in neurological diseases, from functions to therapies. Front Cell Neurosci. 11, 63 (2017).

    Google Scholar 

  15. Allan, S. M., Tyrrell, P. J. & Rothwell, N. J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629–640 (2005).

    Google Scholar 

  16. Heneka, M. T. et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 493, 674–678 (2013).

    Google Scholar 

  17. Gordon, R. & Albornoz, E. A. Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Sci. Transl. Med 10, eaah4066 (2018).

    Google Scholar 

  18. Walsh, J. G. et al. Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS. Retrovirology 11, 35 (2014).

    Google Scholar 

  19. Kaul, M. & Lipton, S. A. Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr. HIV Res. 4, 307–318 (2006).

    Google Scholar 

  20. Michael, N. L. & Moore, J. P. HIV-1 entry inhibitors: evading the issue. Nat. Med. 5, 740–742 (1999).

    Google Scholar 

  21. Maung, R. et al. CCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120. J. Immunol. 193, 1895–1910 (2014).

    Google Scholar 

  22. Sun, N.-N. et al. Mir-21 mediates the inhibitory effect of Ang (1–7) on AngII-induced NLRP3 inflammasome activation by targeting Spry1 in lung fibroblasts. Sci. Rep. 7, 14369 (2017).

    Google Scholar 

  23. Doitsh, G. et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505, 509–514 (2014).

    Google Scholar 

  24. Ahmad, F. et al. Evidence of inflammasome activation and formation of monocyte-derived ASC specks in HIV-1 positive patients. Aids 32, 299–307 (2018).

    Google Scholar 

  25. Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248–255 (2015).

    Google Scholar 

  26. Afonina, I. S., Zhong, Z., Karin, M. & Beyaert, R. Limiting inflammation-the negative regulation of NF-kappaB and the NLRP3 inflammasome. Nat. Immunol. 18, 861–869 (2017).

    Google Scholar 

  27. Liu, J., Xu, C., Chen, L., Xu, P. & Xiong, H. Involvement of Kv1.3 and p38 MAPK signaling in HIV-1 glycoprotein 120-induced microglia neurotoxicity. Cell Death Dis. 3, e254 (2012).

    Google Scholar 

  28. Xu, C. et al. HIV-1 gp120 enhances outward potassium current via CXCR4 and cAMP-dependent protein kinase A signaling in cultured rat microglia. Glia 59, 997–1007 (2011).

    Google Scholar 

  29. Ogishi, M. & Yotsuyanagi, H. Prediction of HIV-associated neurocognitive disorder (HAND) from three genetic features of envelope gp120 glycoprotein. Retrovirology 15, 12 (2018).

    Google Scholar 

  30. Barak, O. et al. Involvement of brain cytokines in the neurobehavioral disturbances induced by HIV-1 glycoprotein120. Brain Res. 933, 98–108 (2002).

    Google Scholar 

  31. Thaney, V. E. et al. Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research. J. Neurovirol. 24, 156–167 (2018).

    Google Scholar 

  32. Ransohoff, R. M. A polarizing question: do M1 and M2 microglia exist? Nat. Neurosci. 19, 987–991 (2016).

    Google Scholar 

  33. Andersen, I. L., Boe, K. E., Foerevik, G., Janczak, A. M. & Bakken, M. Behavioural evaluation of methods for assessing fear responses in weaned pigs. Appl Anim. Behav. Sci. 69, 227–240 (2000).

    Google Scholar 

  34. Baroja-Mazo, A. et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat. Immunol. 15, 738–748 (2014).

    Google Scholar 

  35. Chivero, E. T., Guo, M. L. & Periyasamy, P. HIV-1 Tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation. J. Neurosci. 37, 3599–3609 (2017).

    Google Scholar 

  36. Ichinohe, T., Pang, I. K. & Iwasaki, A. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 11, 404–410 (2010).

    Google Scholar 

  37. Hafner-Bratkovic, I., Bencina, M., Fitzgerald, K. A., Golenbock, D. & Jerala, R. NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1beta and neuronal toxicity. Cell Mol. Life Sci. 69, 4215–4228 (2012).

    Google Scholar 

  38. Negash, A. A. et al. IL-1beta production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 9, e1003330 (2013).

    Google Scholar 

  39. Chandy, K. G. & Norton, R. S. Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease. Curr. Opin. Chem. Biol. 38, 97–107 (2017).

    Google Scholar 

  40. Chiang, E. Y. et al. Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions. Nat. Commun. 8, 14644 (2017).

    Google Scholar 

  41. Maezawa, I. et al. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept. Brain 141, 596–612 (2018).

    Google Scholar 

  42. Upadhyay, S. K. et al. Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance. Proc. Natl Acad. Sci. USA 110, E2239–E2248 (2013).

    Google Scholar 

  43. Di Lucente, J., Nguyen, H. M. & Wulff, H. The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo. Glia 66, 1881–1895 (2018).

    Google Scholar 

  44. Liu, X. & Quan, N. Microglia and CNS Interleukin-1: Beyond Immunological Concepts. Front Neurol. 9, 8 (2018).

    Google Scholar 

  45. Corasaniti, M. T. et al. 17beta-estradiol reduces neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat. Neurotoxicology 26, 893–903 (2005).

    Google Scholar 

  46. Zhou, C. et al. Interleukin-1beta downregulates the L-type Ca2 + channel activity by depressing the expression of channel protein in cortical neurons. J. Cell Physiol. 206, 799–806 (2006).

    Google Scholar 

  47. Yu, J. et al. IL-1beta stimulates brain-derived neurotrophic factor production in eutopic endometriosis stromal cell cultures: a model for cytokine regulation of neuroangiogenesis. Am. J. Pathol. 188, 2281–2292 (2018).

    Google Scholar 

  48. Corasaniti, M. T. et al. Evidence that increases of mitochondrial immunoreactive IL-1beta by HIV-1gp120 implicate in situ cleavage of pro-IL-1beta in the neocortex of rat. J. Neurochem. 78, 611–618 (2001).

    Google Scholar 

  49. Russo, R. et al. Evidence implicating matrix metalloproteinases in the mechanism underlying accumulation of IL-1beta and neuronal apoptosis in the neocortex of HIV/gp120-exposed rats. Int Rev. Neurobiol. 82, 407–421 (2007).

    Google Scholar 

  50. Lipton, S. A. & Gendelman, H. E. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332, 934–940 (1995).

    Google Scholar 

  51. Block, M. L., Zecca, L. & Hong, J. S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57–69 (2007).

    Google Scholar 

  52. Valderrama, J. A., Riestra, A. M., Gao, N. J. & LaRock, C. N. Group A streptococcal M protein activates the NLRP3 inflammasome. Nat. Microbiol. 2, 1425–1434 (2017).

    Google Scholar 

  53. Ashraf, T. et al. Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation. J. Neuroinflamm. 11, 91 (2014).

    Google Scholar 

  54. Bachis, A., Cruz, M. I. & Mocchetti, I. M‐tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T‐tropic gp120 in rat striatum. Eur. J. Neurosci. 32, 570–578 (2010).

    Google Scholar 

  55. Wang, Y., Liao, J., Tang, S. J., Shu, J. & Zhang, W. HIV-1gp120 upregulates brain-derived neurotrophic factor (BDNF) expression in BV2 cells via the Wnt/β-catenin signaling pathway. J. Mol. Neurosci. 62, 199–208 (2017).

    Google Scholar 

  56. Luo, W., Fang, W., Li, S. & Yao, K. Aberrant expression of nuclear vimentin and related epithelial–mesenchymal transition markers in nasopharyngeal carcinoma. Int. J. Cancer 131, 1863–1873 (2012).

    Google Scholar 

  57. Huang, S.-H. et al. Vimentin, a Novel NF-κB regulator, is required for meningitic Escherichia coli K1-induced pathogen invasion and PMN transmigration across the blood-brain barrier. PloS One 11, e0162641 (2016).

    Google Scholar 

  58. Dos Santos, G. et al. Vimentin regulates activation of the NLRP3 inflammasome. Nat. Commun. 6, 6574 (2015).

    Google Scholar 

  59. Hol, E. M. & Pekny, M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr. Opin. Cell Biol. 32, 121–130 (2015).

    Google Scholar 

  60. El-Barbary, A. M., Kassem, E. M., El-Sergany, M. A., SALWA, A. & Eltomey, M. A. Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide. J. Rheumatol. 38, 828–834 (2011).

    Google Scholar 

  61. Thomas, E. K. et al. Anti-idiotypic antibody to the V3 domain of gp120 binds to vimentin: a possible role of intermediate filaments in the early steps of HIV-1 infection cycle. Viral Immunol. 9, 73–87 (1996).

    Google Scholar 

  62. Noda, H., Takeuchi, H., Mizuno, T. & Suzumura, A. Fingolimod phosphate promotes the neuroprotective effects of microglia. J. Neuroimmunol. 256, 13–18 (2013).

    Google Scholar 

  63. Meeker, R. B., Poulton, W., Clary, G., Schriver, M. & Longo, F. M. Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis. Exp. Neurol. 275, 182–198 (2016).

    Google Scholar 

  64. Dreyer, E. B., Kaiser, P. K., Offermann, J. T. & Lipton, S. A. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248, 364–367 (1990).

    Google Scholar 

  65. Ashkenazi, A. et al. Polyglutamine tracts regulate beclin 1-dependent autophagy. Nature 545, 108–111 (2017).

    Google Scholar 

  66. Moss, P. J. et al. Macrophage–sensory neuronal interaction in HIV-1 gp120-induced neurotoxicity. Br. J. Anaesth. 114, 499–508 (2014).

    Google Scholar 

  67. Keswani, S. C. et al. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann. Neurol. 54, 287–296 (2003).

    Google Scholar 

  68. Higgins, S., Lee, J. S., Ha, L. & Lim, J. Y. Inducing neurite outgrowth by mechanical cell stretch. BioResearch Open Access 2, 212–216 (2013).

    Google Scholar 

Download references

Acknowledgements

This project was financially supported by the Key Program of the Natural Science Foundation of Guangdong, China (No. 2017B030311017), the National Natural Science Foundation of China (No. 81370740), the Program of the Natural Science Foundation of Guangdong, China (No. 2018A030313845), and the China Postdoctoral Science Foundation (No. 2018M633076).

Author information

Authors and Affiliations

Contributions

S.H., H.C., E.M., X.H., W.Y., and L.W. conceived and designed the experiments. M.E. and S.H. contributed reagents/materials/analysis tools. X.H., W.Y., Q.Z., Z.Z., Yi W., L.Q.L., L.T.L., Yu W., Z.G., J.G., H.Z., Y.L., S.Y., and T.H. performed the experiments and acquired and analyzed the data. X.H., W.Y., J.G., Q.Z., and Z.Z. prepared the figures and L.W., E.M., S.H., and H.C. helped revise them. X.H., S.H., H.C., W.Y., J.G., and L.W. drafted the paper, and S.H., X.H., E.M., H.C., W.Y., B.Z., L.L. and Yi W. revised it. All authors read and approved the final paper.

Corresponding authors

Correspondence to Shenghe Huang or Hong Cao.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

The original online version of this article was revised: Fig 8d and Supplementary Figure 5d have been updated.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, X., Yang, W., Zeng, Z. et al. NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology. Cell Mol Immunol 17, 283–299 (2020). https://doi.org/10.1038/s41423-019-0260-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41423-019-0260-y

Keywords

This article is cited by

Search

Quick links